Find Publications
Refine your search by selecting items below:
Will it Deliver? WTO rules and Canada’s law on compulsory licensing – The continuing challenge of scaling up treatment access – Event at XVI International AIDS Conference
At this session, Brigitte Zirger (Health Canada), Prof. David H. Mwakyusa (Minister for Health and Social Welfare – Tanzania), Bruce Clark (Apotex), Anil Soni (Clinton Foundation), Rachel Kiddell-Monroe (Médecins Sans Frontières) and Richard Elliott (Canadian HIV/AIDS Legal Network) will present their perspectives on their experience with the Canadian law and the 2003 WTO decision, and … Read more
Letter to Prime Minister Stephen Harper re: Global Treatment Access Group
Download and send this letter to the Prime Minister and your local member of Parliament.
Legislating for Health and Human Rights: Model Law on Drug Use and HIV/AIDS (pre-publication version)
The model law resource consists of eight modules, addressing the following issues: – Criminal law reform – Treatment for drug dependence – Sterile syringe programs – Supervised drug consumption facilities – Prisons – Outreach and information – Stigma and discrimination – Heroin prescription programs Each of the eight modules in this series is a stand-alone … Read more
Intellectual Property and Access to HIV/AIDS Treatment – Case Studies
Until now, India, Brazil and Thailand have been among the biggest generic ARV producers, both for their own people and for export. This production has been crucial for the supply of affordable treatment in the developing world. It has resulted in competition between producers, which has reduced the price of many ARVs from as much … Read more
The Jean Chrétien Pledge to Africa Act and its Impact on Improving Access to HIV/AIDS Treatment in Developing Countries
This document assesses some of the measures taken recently to improve access to more affordable ARV therapy in developing countries. It provides a synopsis of the key WTO rules and developments, and of the Canadian law, the concrete benefits of which have yet to be realized.
Letter to Industry Canada re: Addition of oseltamivir phosphate to Schedule 1 to the Patent Act
“On July 1, 2006 the Departments of Industry and Health published, in Part I of the Canada Gazette, the proposed text of an order to amend Schedule 1 to the Patent Act to add “oseltamivir phosphate”, in both capsule form as well as in powder for oral suspension, to the list of patented pharmaceutical products … Read more
Letter to federal Health Minister Tony Clement re: Insite
“As Canada’s national HIV/AIDS organizations and as partners in the Federal Initiative on HIV/AIDS, we write to ask you to extend the regulatory exemption allowing Insite, Vancouver’s safe injection facility, to continue its life-saving work…”
Outcomes of the Symposium on HIV Testing and Human Rights
There are increasing calls by public health authorities and policy-makers to modify or abandon the well-established model of voluntary counselling and testing (VCT) for HIV in favour of models that do not necessarily preserve the elements of informed consent, pre- and post-test counselling and confi dentiality of test results. This report summarizes the conclusions of … Read more
Statement to the Human Rights Council re: Marginalised groups, sexual orientation and gender identity
Joint written statement submitted by: Action Canada for Population and Development, Canadian HIV/AIDS Legal Network, Center for Women’s Global Leadership, Global Rights, International Service for Human Rights, International Women\’s Health Coalition, and Women for Women’s Human Rights (New Ways), non-governmental organizations in special consultative status.
Page 75 of 100